Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment

Food and Chemical Toxicology

Volumn 70, Issue , 2014, Pages 151-156

  Phyu, Moe Pwint ^a   Tangpong, Jitbanjong ^a  

^a WALAILAK UNIVERSITY   (Thailand)

Author keywords

Acetylcholinesterase (AChE); Antioxidant activity; Cognitive impairment; Lead (Pb); Xanthone

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA TOCOPHEROL; DRINKING WATER; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LEAD ACETATE; NITRIC OXIDE; PHENOL DERIVATIVE; SUPEROXIDE; XANTHONE DERIVATIVE; LEAD; NEUROPROTECTIVE AGENT; PLANT EXTRACT; XANTHONE;

ACETYLCHOLINESTERASE BLOOD LEVEL; ACETYLCHOLINESTERASE BRAIN LEVEL; AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR DISORDER; BIOCHEMICAL COMPOSITION; BRAIN LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEFECT; FORCED SWIM TEST; GARCINIA MANGOSTANA; IC 50; IN VITRO STUDY; IN VIVO STUDY; LEAD POISONING; LEARNING DISORDER; MAZE TEST; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; TREATMENT DURATION; ANIMAL; BRAIN; CELL FREE SYSTEM; CHEMICALLY INDUCED; CHEMISTRY; COGNITION; COGNITION DISORDERS; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; MEMORY DISORDERS; METABOLISM; NEUROTOXICITY SYNDROMES; TOXICITY;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; CELL-FREE SYSTEM; COGNITION; COGNITION DISORDERS; GARCINIA MANGOSTANA; LEAD; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED ICR; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; OXIDATIVE STRESS; PLANT EXTRACTS; XANTHONES;

EID: 84902002566     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.04.035     Document Type: Article

References (53)

1. Ahamed M., Siddiqui M.K.J. Low levels lead exposure and oxidative stress: current opinions. Clin. Chim. Acta 2007, 383:57-64.
2. Alfano D.P., Petit T.L., LeBoutillier J.C. Development and plasticity of the hippocampal-cholinergic system in normal and early lead exposed rats. Brain Res. 1983, 312:117-124.
3. Aruoma O. Assessment of potential prooxidant and antioxidant actions. J. Am. Oil Chem. Soc. 1996, 73:1617-1625.
4. Basha M.R., Wei W., Brydie M., Razmiafshari M., Zawia N.H. Lead-induced developmental perturbations in hippocampal Sp1 DNA-binding are prevented by zinc supplementation: in vivo evidence for Pb and Zn competition. Int. J. Dev. Neurosci. 2003, 21:1-12.
5. Basha D.C., Rani M.U., Devi C.B., Kumar M.R., Reddy G.R. Perinatal lead exposure alters postnatal cholinergic and aminergic system in rat brain: reversal effect of calcium co-administration. Int. J. Dev. Neurosci. 2012, 30:343-350.
6. 4. BMC Complement Altern. Med. 2013, 13:262.
7. Chen L.G., Yang L.L., Wang C.C. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem. Toxicol. 2008, 46:688-693.
8. Dan S., Sujuan Z., Yongfeng W., Lingfang Y. Antioxidant activity of mangostin in cell free system and its effect on K562 leukemia cell line in photodynamic therapy. Acta Biochim. Biophys. Sicina. 2009, 41:1033-1043.
9. Devi C.B., Reddy G.H., Prasanthi R.P., Chetty C.S., Reddy G.R. Developmental lead exposure alters mitochondrial monoamine oxidase and synaptosomal catecholamine levels in rat brain. Int. J. Dev. Neurosci. 2005, 23:375-381.
10. Dewanjee S., Sahu R., Karmakar S., Gangopadhyay M. Toxic effects of lead exposure in Wistar rats: involvement of oxidative stress and the beneficial role of edible jute (Corchorus olitorius) leaves. Food Chem. Toxicol. 2013, 55:78-91.
11. Di Matteo V., Esposito E. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Curr. Drug Targets CNS Neurol. Disord. 2003, 2:95-107.
12. Ellman G.L., Courtney K.D., Andres V.R., Featherstone M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharm. 1961, 7:88-95.
13. Erac N., Gurer-Orhan H., Aykin-Burns N. Toxic metals and oxidative stress Part 1: Mechanisms involved in metal induced oxidative damage. Curr. Top. Med. Chem. 2001, 1:529-539.
14. Florea A.M., Busselberg D. Occurrence, use and potential toxic effects of metals and metal compounds. Biometals 2006, 19:419-427.
15. Gülcin I., Alici H.A., Cesur M. Determination of in vitro antioxidant radical scavenging activities of propofol. Chem. Pharm. Bull. 2005, 53:281-285.
16. Guzmán-Beltrán S., Orozco-Ibarra M., González-Cuahutencos O., Victoria-Mares S., Merchand-Reyes G., Medina-Campos O.N., Pedraza-Chaverri J. Neuroprotective effect and reactive oxygens pecies scavenging capacity of mangosteen pericarp extract in cultured neurons. Curr. Topics Nutr. Res. 2008, 6:149-158.
17. Hagerman A.E., Riedl K.M., Jones G.A., Sovik K.N., Ritchard N.T., Hartzfeld P.W. High molecular weight plant polyphenolics (tannins) as biological antioxidants. J. Agric. Food Chem. 1998, 46:1887-1892.
18. Hatano T., Edamatsu R., Mori A. Effects of interaction of tannins with coexisting substances. Chem. Pharm. Bull. 1989, 37:2016-2021.
19. Jiang D.J., Dai Z., Li Y.J. Pharmacological effects of xanthones as cardiovascular protective agents. Cardiovasc. Drug Rev. 2004, 22:91-102.
20. Katzung B.G. Basic and Clinical Pharmacology: Introduction to Autonomic Pharmacology 2001, The McGraw Hill Companies, pp. 75-91. eighth ed.
21. Kondo M., Zhang L., Ji H., Kou Y., Ou B. Bioavailability and antioxidant effects of a xanthone-rich Mangosteen (Garcinia mangostana) product in humans. J. Agric. Food Chem. 2009, 57:8788-8792.
22. Kuhlmann A.C., McGlothan J.L., Guilarte T.R. Developmental lead exposure causes spatial learning deficits in adult rats. Neurosci. Lett. 1997, 233:101-104.
23. Lidsky T.I., Schneider J.S. Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain 2003, 126:5-19.
24. Lobo V., Patil A., Phatak A., Chandra N. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn. Rev. 2010, 4:118-126.
25. Marquez-Valadez B., Lugo-Huitron R., Valdivia-Cerda V., Miranda-Ramirez L.R., Perez-De La Cruz V., Gonzalez-Cuahutencos O., Rivero-Cruz I., Mata R., Santamaria A., Pedraza-Chaverri J. The natural xanthone alpha-mangostin reduces oxidative damage in rat brain tissue. Nutr. Neurosci. 2009, 12:35-42.
26. Milatovic D., Gupta R.C., Aschner M. Anticholinesterase toxicity and oxidative stress. Sci. World J. 2006, 6:295-310.
27. 24. Nitric Oxide 2004, 11:201-207.
28. Morris R. Development of water maze procedure for studying spatial learning in rat. J. Neurosci. Method. 1984, 11:47-60.
29. Mortensen M.E., Walson P.D. Chelation therapy for childhood lead poisoning. The changing scene in the 1990. Clin. Pediatr. (Phila). 1993, 32:284-291.
30. Ng F., Berk M., Dean O., Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int. J. Neuropsycho-pharmacol. 2007, 11:851-876.
31. Pedraza-Chaverri J., Cardenas-Rodriguez N., Orozco-Ibarra M., Perez-Rojas J.M. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem. Toxicol. 2008, 46:3227-3239.
32. Pedraza-Chaverrí J., Reyes-Fermín L.M., Nolasco-Amaya E.G., Orozco-Ibarra M., Medina-Campos O.N., González-Cuahutencos O., Rivero-Cruz I., Mata R. ROS scavenging capacity and neuroprotective effect of alpha-mangostin against 3-nitropropionic acid in cerebellar granule neurons. Exp. Toxicol. Pathol. 2009, 61:491-501.
33. Pham-Huy L.A., He H., Pham-Huy C. Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. 2008, 4:89-96.
34. Porru S., Alessio L. The use of chelating agents in occupational lead poisoning. Occup. Med. (Lond). 1996, 46:41-48.
35. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
36. Re R., Pellegrini N., Proteggente A., Pannala A., Yang M., Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26:1231-1237.
37. Reyes-Fermín L.M., González-Reyes S., Tarco-Álvarez N.G., Hernández-Nava M., Orozco-Ibarra M., Pedraza-Chaverri J. Neuroprotective effect of α-mangostin and curcumin against iodoacetate-induced cell death. Nutr. Neurosci. 2012, 15:34-41.
38. Rojas P., Serrano-Garcia N., Medina-Campos O.N., Pedraza-Chaverri J., Ogren S.O., Rojas C. Antidepressant-like effect of a Ginkgo biloba extract (EGb761) in the mouse forced swimming test: Role of oxidative stress. Neurochem. Int. 2011, 59:628-636.
39. Sarandol A., Sarandol E., Eker S.S., Erdinc S., Vatansever E., Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum. Psychopharmacol. 2007, 22:67-73.
40. Shih T.M., Hanin I. Effects of chronic lead exposure on levels of acetylcholine and choline and on acetylcholine turnover rate in rat brain areas in vivo. J. Psychopharmacol. 1978, 58:263-269.
41. Shukla S., Mehta A., Bajpai V.K., Shukla S. In vitro antioxidant activity and total phenolic content of ethanolic leaf extract of Stevia rebaudiana Bert. Food Chem. Toxicol. 2009, 47:2338-2343.
42. Sim K.S., Sri Nurestri A.M., Norhanom A.W. Phenolic content and antioxidant activity of Pereskia grandifolia Haw. (Cactaceae) Extracts Pharmacogn. Mag. 2010, 6:248-254.
43. Smith C.C., Dickson A.C., Betteridge D.J. Non enzymatic glycosylation of plasma lipoprotein in vitro. Diabetes Res. 1985, 2:227-282.
44. Tangpong J., Satarug S. Alleviation of lead poisoning in the brain with aqueous leaf extract of the Thunbergia laurifolia (Linn.). Toxicol. Lett. 2010, 198:83-88.
45. Tangpong J., Miriyala S., Noel T., Sinthupibulyakit C., Jungsuwadee P., St.Clair D.K. Doxorubicin induced central nervous system toxicity and protection by xanthone derivative of Garcinia mangostana. Neuorosci. 2011, 175:292-299.
46. Thachil A.F., Mohan R., Bhugra D. The evidence base of complementary and alternative therapies in depression. J. Affect. Disord. 2007, 97:23-35.
47. Toscano C.D., Guilarte T.R. Lead neurotoxicity: from exposure to molecular effects. Brain Res. Brain Res. Rev. 2005, 49:529-554.
48. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
49. Vázquez A., Peña de Ortiz S. Lead (Pb(+2)) impairs long-term memory and blocks learning-induced increases in hippocampal protein kinase C activity. Toxicol. Appl. Pharmacol. 2004, 200:27-39.
50. White L.D., Cory-Slechta D.A., Gilbert M.E., Tiffany-Castiglioni E., Zawia N.H., Virgolini M., Rossi-George A., Lasley S.M., Qian Y.C., Basha M.R. New and evolving concepts in the neurotoxicology of lead. Toxicol. Appl. Pharmacol. 2007, 225:1-27.
51. Winder C., Kitchen I. Lead neurotoxicity: a review of the biochemical, neurochemical and drug induced behavioural evidence. Prog. Neurobiol. 1984, 22:59-87.
52. Xu J., Lian L., Wu C., Wang X., Fu W., Xu L. Lead induces oxidative stress, DNA damage and alteration of p53, Bax and Bcl-2 expressions in mice. Food Chem. Toxicol. 2008, 46:1488-1494.
53. Yang Y., Ma Y., Ni L., Zhao S., Li L., Zhang J., Fan M., Liang C., Cao J., Xu L. Lead exposure through gestation-only caused long-term learning/memory deficits in young adult offspring. Exp. Neurol. 2003, 184:489-495.